Literature DB >> 7626129

Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.

T Mizutani1, N Kato, M Hirota, K Sugiyama, A Murakami, K Shimotohno.   

Abstract

Oligonucleotides complementary to the sequences containing the initiator codon, AUG, of the core region of positive-stranded hepatitis C virus (HCV) were tested for their effects on viral translation in a cell-free protein synthesis system and on viral replication in a human T-lymphotropic virus type I infected cell line, MT-2C, which was cloned by the limited dilution method from MT-2 cells and showed more efficient HCV replication than an uncloned population of MT-2 cells. Treatment of HCV-infected MT-2C cells with the antisense oligonucleotide (10 microM) had a dramatic inhibitory effect on viral replication. This result suggests that the antisense oligonucleotide complementary to the sequence close to the initiation codon of the core region might be useful as an antiviral agent against HCV replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626129     DOI: 10.1006/bbrc.1995.2055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.

Authors:  E A Biessen; H Vietsch; E T Rump; K Fluiter; J Kuiper; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 2.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Structure of the 3' terminus of the hepatitis C virus genome.

Authors:  T Tanaka; N Kato; M J Cho; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.

Authors:  O Vidalin; M E Major; B Rayner; J L Imbach; C Trépo; G Inchauspé
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding.

Authors:  R Jubin; N E Vantuno; J S Kieft; M G Murray; J A Doudna; J Y Lau; B M Baroudy
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.

Authors:  N Sakamoto; C H Wu; G Y Wu
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

7.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

8.  Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2.

Authors:  T Mizutani; N Kato; S Saito; M Ikeda; K Sugiyama; K Shimotohno
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Biological significance of HCV in various kinds of lymphoid cells.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Int J Microbiol       Date:  2012-02-22

10.  RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.

Authors:  Margit Mutso; Andrei Nikonov; Arno Pihlak; Eva Žusinaite; Liane Viru; Anastasia Selyutina; Tõnu Reintamm; Merike Kelve; Mart Saarma; Mati Karelson; Andres Merits
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.